IR-Med Inc., a medical device company, engages in the development of non-invasive devices for various medical indications. The company's development products pipeline consists of PressureSafe, a handheld skin-agnostic optical monitoring device that supports early detection of pressure injuries to the skin and underlying tissue primarily caused by prolonged pressure associated with bed confinement; DiaSafe, a handheld optical monitoring device, which supports early detection of diabetic foot ulcers in lower limb skin and underlying tissue caused by prolonged pressure on the sole of diabetic patients; and Nobiotics, an otoscope to support physicians with an immediate indication as to whether mid-ear, a common malady in children. IR-Med Inc. is headquartered in Rosh Pinna, Israel.
Frequently asked questions
What sector does International Display Advertising Inc (IRME) operate in?
International Display Advertising Inc belongs to the Healthcare sector and operates in the Medical Devices industry.
What is International Display Advertising Inc (IRME) current stock price?
As of the latest data, International Display Advertising Inc stock price is $0.00, with a previous close of $0.00.
What is International Display Advertising Inc (IRME) current market capitalization?
International Display Advertising Inc market cap is approximately 231.13 thousand.
What is International Display Advertising Inc (IRME) Earnings Per Share (EPS)?
The trailing EPS is -$0.04.
Does International Display Advertising Inc (IRME) pay dividends?
No. International Display Advertising Inc does not pay a dividend.
What is International Display Advertising Inc (IRME) beta (volatility) score?
International Display Advertising Inc has a beta of 0.572, indicating lower volatility than the overall market.